A randomised, double-blind, placebo-controlled, parallel-group, 52 week study to evaluate the efficacy and safety of oral DHEA therapy in postmenopausal women of sexual function wellbeing and vasomoto
- Davis, Susan (Primary Chief Investigator (PCI))
- Bell, Robin (Chief Investigator (CI))
- Panjari, Mary, (Chief Investigator (CI))
- Papalia, Mary-Anne, (Chief Investigator (CI))
Project: Research